Oncologist and Cancer Commons Medical Director Kevin Knopf, MD, will speak next month at TiEcon 2017, a technology conference in Santa Clara, CA. He’ll join three other experts to discuss the future of personalized medicine. From the program:
A new era of personalized medicine has made its way into the world of healthcare. We will discuss novel approaches for designing disease treatment and prevention that integrates with an individual’s genetic profile, environment and lifestyle.The future is here — let’s hear from industry luminaries on how digital health entrepreneurs and the healthcare industry as a whole are preparing for massive disruption.
Kevin’s presentation will take place on May 5 at 3:00 pm. For more information, visit the TiEcon website.
Update 3-1-17: A video of this event has now been released. Watch it below.
This year’s Precision Medicine World Conference in Mountain View, California, was well-attended by many members of Cancer Commons, who shared in the scientific discoveries that will lead the way to more personalized, accurate, and effective cancer care. Precision medicine is a rapidly evolving field with many breakthroughs in science, technology, and diagnosis that is transforming the way cancer care is practiced at the bedside.
A special session was co-chaired by Cancer Commons board member Larry Marton and Lincoln Nadauld, director of the personalized oncology program at Intermountain Healthcare in Utah. The session also featured Cancer Commons medical director Kevin Knopf, Mountain View oncologist Edmund Tai, and Tim Collins, who is corporate vice president of operations and research at Scripps Health in San Diego. Continue reading…
On May 21, HackCancer held its 4th Annual White Party in San Francisco. 100% of the net proceeds go to Cancer Commons and will help us get the right treatments to the right patients at the right time. A huge thank you to the organizers and to all who attended!
Above: Dominique Kim and Toni Alejandria show their support at the HackCancer White Party. See more photos of the event on our Facebook page.
We’re thrilled to announce that South by Southwest (SXSW) has named Cancer Commons founder Marty Tenenbaum a 2016 Dewey Winburne Community Service Award Honoree. Marty joins nine other remarkable honorees, all of whom use digital technology to help others. They were selected based on their qualities of “community, compassion, care, education and positive energy.”
Marty—along with the other awardees—will share his story on March 13, 2016 in Austin, TX.
Cancer Commons founder Marty Tenenbaum spoke last weekend at Medicine X, Stanford University’s conference for new ideas in medicine and healthcare. He told the story of his personal melanoma fight, and how difficult it was to find the information he needed to beat his cancer. This experience led him to found Cancer Commons, with the goal of developing a rapid learning platform to help patients explore their options and make the best, most personalized decisions about their cancer care.
The Shine Project and Cancer Commons invite you to join us for a night of music, dancing, and community. We’re celebrating the lives of those who have passed due to cancer, and the lives that we’re still living. All proceeds will enable Cancer Commons to help patients navigate their treatment.
When: Friday, October 23, 2015, 7:00 PM PST
Where: Fox Theatre Redwood City, CA
Heather Rangel is a Deloitte partner and a Cancer Commons Pathfinder donor and volunteer. She heads up Project Shine, in which she works with her extensive network to support Cancer Commons. Heather kick-started the campaign by setting a goal she wasn’t sure she could meet—swimming a 10,000 meter butterfly—and raised more than twice her target amount. I spoke with her about her achievement.Continue reading…
Update: This event has passed, but you can watch the full conversation here:
See Cancer Commons founder Marty Tenenbaum discuss “Big Questions, Big Data, and Big Science” on March 19 in Phoenix, Arizona. The event is hosted by AZBio, and will feature Marty in conversation with Joshua LaBaer, MD, PhD, of Arizona State University’s Biodesign Institute. Visit the event page to learn more and register to attend.
Seventeen years ago, Cancer Commons founder Marty Tenenbaum learned he had melanoma. He leapt into action. He wanted the best treatment options he could possibly find.
“When you’re diagnosed, you’re put into this strange new world with no guidance,” Marty said. “You hit the search engines, and you’re just overwhelmed with information that’s mostly irrelevant, incomprehensible, or out of date.” Continue reading…